Skip to main content

Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study

Abstract

IL-10 expression limits inflammation and restricts the size of CNS damage from stroke. In this study, we examined the correlation between cerebral infarction (CI) and serum levels of interleukin-10 (IL-10) using a combination of case-control study and meta-analysis of published data, with an aim of understanding the relevance of serum IL-10 levels to CI development. This study enrolled a total of 169 CI patients admitted to the Second Hospital of Hebei Medical University between May 2011 and November 2014. During the same period, a group of 145 individuals were recruited at the same hospital as healthy controls after thorough physical examination. Serum IL-10 levels were measured by enzyme-linked immunosorbent assay (ELISA). SPSS 19.0 (IBM, 2010, Chicago, IL, USA) and Comprehensive Meta-Analysis 2.0 (CMA 2.0) software were used for data analysis. Serum levels of IL-10 (pg/mL) were significantly lower in CI patients when compared to healthy controls (15.36 ± 3.21 vs. 21.64 ± 5.17, t = 13.12, P < 0.001). In addition, patients with large artery atherosclerosis (LAAS), cardioembolic infarct (CEI), and lacunar infarct (LAC) displayed drastically reduced serum levels of IL-10 (pg/mL) compared to healthy controls (LAAS 14.77 ± 5.21, CEI 15.25 ± 5.10, LAC 16.58 ± 4.92, all P < 0.001). Interestingly, no significant differences were observed in the serum IL-10 levels when pair-wise comparisons were made between these three clinical subtypes of CI (all P > 0.05). Logistic regression analysis indicated that, with the exception of triglyceride (TG) and uric acid (UA) levels (both P > 0.05), the other seven parameters, including fasting blood glucose (FPG), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), creatinine (Cr), systolic blood pressure (SBP), and diastolic blood pressure (DBP), strongly correlated with CI development (all P < 0.05). Meta-analysis of pooled data from nine case-control studies revealed an inverse correlation between the serum IL-10 levels and CI (SMD = 1.797, 95 % CI 0.785~2.810, P = 0.001). Subgroup analysis based on country showed that low serum levels of IL-10 may be the major risk factor for CI in Croatia (SMD = 2.961, 95 % CI 2.480~3.443, P < 0.001) and India (SMD = 1.440, 95 % CI 1.129–1.750, P < 0.001). Further, subgroup analysis based on ethnicity showed that IL-10 serum levels and CI displayed negative relationship in Asians (SMD = 2.522, 95 % CI 0.468~4.576, P = 0.016) but not in Caucasians (P > 0.05). Our study provided convincing evidence that the patients with CI exhibit consistently reduced serum levels of IL-10, and IL-10 may be a major player in the development and progression of CI.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. Rutten-Jacobs LC, Arntz RM, Maaijwee NA, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, de Leeuw FE (2013) Long-term mortality after stroke among adults aged 18 to 50 years. JAMA 309:1136–1144

    CAS  Article  PubMed  Google Scholar 

  3. Liu X, Zhu RX, Li L, He ZY (2014) Association of LOX-1 gene polymorphisms with cerebral infarction in northern Chinese Han population. Lipids Health Dis 13:55

    Article  PubMed  PubMed Central  Google Scholar 

  4. Doehner W, von Haehling S, Suhr J, Ebner N, Schuster A, Nagel E, Melms A, Wurster T et al (2012) Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke. J Am Coll Cardiol 60:346–354

    CAS  Article  PubMed  Google Scholar 

  5. Gjerde G, Naess H (2014) Risk factor burden predicts long-term mortality after cerebral infarction. Acta Neurol Scand 129:173–177

    CAS  Article  PubMed  Google Scholar 

  6. Commins S, Steinke JW, Borish L (2008) The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol 121:1108–1111

    CAS  Article  PubMed  Google Scholar 

  7. Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71–109

    CAS  Article  PubMed  Google Scholar 

  8. Chiba T, Umegaki K (2013) Pivotal roles of monocytes/macrophages in stroke. Mediat Inflamm 2013:759103

    Article  Google Scholar 

  9. Protti GG, Gagliardi RJ, Forte WC, Sprovieri SR (2013) Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke. Arq Neuropsiquiatr 71:846–851

    Article  PubMed  Google Scholar 

  10. Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N (2013) Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 419:136–138

    CAS  Article  PubMed  Google Scholar 

  11. Chang LT, Yuen CM, Liou CW, Lu CH, Chang WN, Youssef AA, Yip HK (2010) Link between interleukin-10 level and outcome after ischemic stroke. Neuroimmunomodulation 17:223–228

    CAS  Article  PubMed  Google Scholar 

  12. PN M (2014) World Medical Association publishes the Revised Declaration of Helsinki. Natl Med J India 27(1):56

    Google Scholar 

  13. Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H et al (2014) Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke—Research for Biomarkers in Ischemic Stroke (REBIOS). Metabolism 63:1093–1103

    CAS  Article  PubMed  Google Scholar 

  14. Tuttolomondo A, Pecoraro R, Casuccio A, Di Raimondo D, Butta C, Clemente G, Della Corte V, Guggino G et al (2015) Peripheral frequency of CD4+ CD28− cells in acute ischemic stroke: relationship with stroke subtype and severity markers. Medicine (Baltimore) 94, e813

    CAS  Article  Google Scholar 

  15. Chen H, Manning AK, Dupuis J (2012) A method of moments estimator for random effect multivariate meta-analysis. Biometrics 68:1278–1284

    Article  PubMed  PubMed Central  Google Scholar 

  16. Jing LY, Jing LL, Liu M (2013) Correlation between neurological deficit in ischemic stroke and inflammatory cytokines. Chin Med Sci 3(6):215–216

  17. Basic KV, Simundic AM, Nikolac N, Topic E, Demarin V (2008) Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem 41:1330–1334

    Article  Google Scholar 

  18. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A (2009) Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 101:929–937

    CAS  PubMed  Google Scholar 

  19. Tuttolomondo A, Pecoraro R, Di Raimondo D, Di Sciacca R, Canino B, Arnao V, Butta C, Della Corte V et al (2014) Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome. Diabetol Metab Syndr 6:28

    Article  PubMed  PubMed Central  Google Scholar 

  20. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A (2003) Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34:671–675

    CAS  Article  PubMed  Google Scholar 

  21. Xie G, Myint PK, Zaman MJ, Li Y, Zhao L, Shi P, Ren F, Wu Y (2013) Relationship of serum interleukin-10 and its genetic variations with ischemic stroke in a Chinese general population. PLoS One 8, e74126

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. Yang Y, Li XZ (2009) ADPN plasma concentration of cerebral stroke is correlated to inflammatory factors. Chin J Behavioral Med Brain Sci 18:1010–1012

    CAS  Google Scholar 

  23. Li B, Liu X, Cao ZG, Li Y, Liu TM, Wang RT (2014) Elevated mean platelet volume is associated with silent cerebral infarction. Intern Med J 44:653–657

    CAS  Article  PubMed  Google Scholar 

  24. Glocker EO, Kotlarz D, Klein C, Shah N, Grimbacher B (2011) IL-10 and IL-10 receptor defects in humans. Ann N Y Acad Sci 1246:102–107

    CAS  Article  PubMed  Google Scholar 

  25. Marousi S, Ellul J, Antonacopoulou A, Gogos C, Papathanasopoulos P, Karakantza M (2011) Functional polymorphisms of interleukin 4 and interleukin 10 may predict evolution and functional outcome of an ischaemic stroke. Eur J Neurol 18:637–643

    CAS  Article  PubMed  Google Scholar 

  26. Trompet S, Pons D, De Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Cobbe SM et al (2007) Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci 1100:189–198

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgments

This research is funded by the Key Research Project of Medical Science of Health and Family Planning Commission of Hebei Province (20100084). We acknowledge the reviewers for their helpful comments on this paper.

Competing Interests

The authors have proclaimed that no existing competing interests.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yifei Zhu.

Additional information

Yifei Zhu and Haiqing Yang contributed equally to this research.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Yang, H., Diao, Z. et al. Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study. Mol Neurobiol 53, 2698–2704 (2016). https://doi.org/10.1007/s12035-015-9368-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9368-y

Keywords

  • Cerebral infarction
  • IL-10
  • Large artery atherosclerosis
  • Cardioembolic infarct
  • Lacunar infarct
  • Inflammatory cytokines
  • Anti-inflammatory cytokines
  • Case-control study